NO934721L - Hemmere av HIV-protease som er nyttige for behandling av AIDS - Google Patents
Hemmere av HIV-protease som er nyttige for behandling av AIDSInfo
- Publication number
- NO934721L NO934721L NO934721A NO934721A NO934721L NO 934721 L NO934721 L NO 934721L NO 934721 A NO934721 A NO 934721A NO 934721 A NO934721 A NO 934721A NO 934721 L NO934721 L NO 934721L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- heterocycle
- aids
- inhibitors
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det blir beskrevet en forbindelse med formel (I):. hvor. R og R° uavhengig er valgt blant hydrogen, ( C^- C^)alkyl, aryltC^)alkyl,. heterocyklus(C-C)alkyl eller umettet heterocvklus(C-C)alkyl; eller. R og R*1 er kombinert med nitrogenet til hvilket de er bundet for å danne en heterocyklus eller umettet heterocyklus med den forutsetning at nitrogen-atomet Ikke kan være kvaternlsert;. Z er en gruppe som har strukturen:. Rer hydrogen, halo, (Cy-C^alkyl, aryl( C^- C^)alkyl, (Cj-Cf,Jalkoksy, (Cj-Cfjjalkyltio, amino, (^-0)alkylamlno, di(C1-C4 )alkylamlno, karbamoyl eller N-(C1-C4 )alkylkarbamoyl;. rer aryl, heterocyklus, umettet heterocyklus, (C-^Jcykloalkyl eller -S-R, hvor Rer aryl, heterocyklus,. umettet heterocyklus eller (C5-C7 )cykloalkyl;. X er en gruppe som har strukturen:. eller et farmasøytisk akseptabelt salt av disse.Forbindelsen med formel (I) er hemmere av HIV-protease og er anvendelige i farmasøytisk formuleringer for behandling og/eller forhindring av HIV-infeksJon og/eller AIDS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99562192A | 1992-12-22 | 1992-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO934721D0 NO934721D0 (no) | 1993-12-20 |
NO934721L true NO934721L (no) | 1994-06-23 |
Family
ID=25542022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934721A NO934721L (no) | 1992-12-22 | 1993-12-20 | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0609625A1 (no) |
JP (1) | JPH06256277A (no) |
KR (1) | KR940014336A (no) |
CN (1) | CN1092410A (no) |
AU (1) | AU5252993A (no) |
BR (1) | BR9305161A (no) |
CA (1) | CA2112052A1 (no) |
CO (1) | CO4180513A1 (no) |
CZ (1) | CZ281393A3 (no) |
FI (1) | FI935780A (no) |
HU (1) | HUT69703A (no) |
IL (1) | IL108098A0 (no) |
MX (1) | MX9308025A (no) |
NO (1) | NO934721L (no) |
PL (1) | PL301578A1 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5747540A (en) * | 1996-10-21 | 1998-05-05 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
WO2002049993A2 (en) * | 2000-09-29 | 2002-06-27 | Neurogen Corporation | High affinity small molecule c5a receptor modulators |
WO2001070672A2 (en) | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
CA2454059A1 (en) * | 2001-07-19 | 2003-01-30 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
AU2002343483A1 (en) | 2001-10-04 | 2003-04-14 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
AU2003303141A1 (en) | 2002-04-30 | 2004-07-22 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer's disease |
JP4721214B2 (ja) * | 2004-09-14 | 2011-07-13 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法 |
JP4698991B2 (ja) * | 2004-09-14 | 2011-06-08 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法 |
WO2006110668A1 (en) | 2005-04-08 | 2006-10-19 | Comentis, Inc. | Compounds which inhibit beta-secretase activity and methods of use thereof |
EP2307345A4 (en) * | 2008-07-01 | 2012-05-02 | Purdue Research Foundation | NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE |
CN110872251A (zh) * | 2019-11-28 | 2020-03-10 | 卡博金艾美斯医药(上海)有限公司 | N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
-
1993
- 1993-12-15 MX MX9308025A patent/MX9308025A/es unknown
- 1993-12-17 CZ CZ932813A patent/CZ281393A3/cs unknown
- 1993-12-20 HU HU9303677A patent/HUT69703A/hu unknown
- 1993-12-20 PL PL93301578A patent/PL301578A1/xx unknown
- 1993-12-20 CO CO93423578A patent/CO4180513A1/es unknown
- 1993-12-20 NO NO934721A patent/NO934721L/no unknown
- 1993-12-20 EP EP93310355A patent/EP0609625A1/en not_active Withdrawn
- 1993-12-20 IL IL10809893A patent/IL108098A0/xx unknown
- 1993-12-20 AU AU52529/93A patent/AU5252993A/en not_active Abandoned
- 1993-12-21 FI FI935780A patent/FI935780A/fi not_active Application Discontinuation
- 1993-12-21 CN CN93112960A patent/CN1092410A/zh active Pending
- 1993-12-21 JP JP5321876A patent/JPH06256277A/ja not_active Withdrawn
- 1993-12-21 CA CA002112052A patent/CA2112052A1/en not_active Abandoned
- 1993-12-21 BR BR9305161A patent/BR9305161A/pt not_active Application Discontinuation
- 1993-12-22 KR KR1019930029120A patent/KR940014336A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2112052A1 (en) | 1994-06-23 |
HUT69703A (en) | 1995-09-28 |
CN1092410A (zh) | 1994-09-21 |
PL301578A1 (en) | 1994-06-27 |
NO934721D0 (no) | 1993-12-20 |
JPH06256277A (ja) | 1994-09-13 |
IL108098A0 (en) | 1994-04-12 |
FI935780A0 (fi) | 1993-12-21 |
EP0609625A1 (en) | 1994-08-10 |
AU5252993A (en) | 1994-07-07 |
BR9305161A (pt) | 1994-11-01 |
CZ281393A3 (en) | 1994-07-13 |
HU9303677D0 (en) | 1994-04-28 |
MX9308025A (es) | 1994-08-31 |
FI935780A (fi) | 1994-06-23 |
KR940014336A (ko) | 1994-07-18 |
CO4180513A1 (es) | 1995-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO934721L (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS | |
NZ505675A (en) | N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents | |
NO954427L (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
NO905322D0 (no) | Aminosyrederivater. | |
DK0467248T3 (da) | Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf | |
EP0638560A4 (en) | MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *. | |
DK0951474T3 (da) | Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf | |
NO934719L (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS | |
FI915819A0 (fi) | Hiv- proteas-inhibitorer. | |
DK1142887T3 (da) | 5,6-Dihydropyronderivater som proteaseinhibitorer og antivirale midler | |
NZ507560A (en) | Hydroxamic acid derivatives as antibacterials | |
SE0201194D0 (sv) | New compounds | |
WO1995014011A3 (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents | |
AU6948091A (en) | Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use | |
KR930002319A (ko) | Aids 치료에 유용한 hiv 프로테아제의 억제제 | |
CA2183234A1 (en) | Agent for prophylaxis and treatment of thromboxane a2-mediated diseases | |
WO1990003172A3 (en) | Bile acids for treatment of viral infections | |
TH14432A (th) | สารยับยั้ง hiv โปรตีเอสที่เป็นประโยชน์สำหรับการบำบัดเอดส์ |